User:Dustin Soe/Sandbox 1
From Proteopedia
(Difference between revisions)
| Line 2: | Line 2: | ||
<StructureSection load='6OB0' size='350' frame='true' side='right' caption='Lipoprotein Lipase Biological Assembly' scene=''> | <StructureSection load='6OB0' size='350' frame='true' side='right' caption='Lipoprotein Lipase Biological Assembly' scene=''> | ||
==Introduction== | ==Introduction== | ||
| - | + | A lipase is an enzyme that is capable of catalyzing the hydrolysis of fats/lipids which are consumed through oils. It is encoded by the p22 region in chromosome 8. Once synthesized, it is secreted into the inter interstitial space in several tissues. The main site of action for LPL is in the capillary lumen within muscle and adipose tissue. | |
| + | [https://en.wikipedia.org/wiki/Lipoprotein_lipase LPL Wiki] | ||
[https://en.wikipedia.org/wiki/Lipase Lipases] | [https://en.wikipedia.org/wiki/Lipase Lipases] | ||
== Function == | == Function == | ||
| - | + | The function of this lipase is to hydrolyze triglycerides of very low density lipoproteins (VLDL) and to aid in the delivery of lipid nutrients to vital tissues. | |
| - | == Disease == | + | ==Mechanism== |
| - | + | The transition state of the catalytic triad is stabilized by the <scene name='87/877516/Oxyanion_hole_master/1'>Oxyanion Hole</scene>. <scene name='87/877516/Catalytic_triad_master/1'>Catalytic Triad</scene> | |
| - | + | == Relevance & Disease == | |
| - | + | LPL is an extremely important enzyme, in that it breaks down triglycerides carried on VLDL, which leads to the reduction of cholesterol buildup. Cholesterol build up is a very serious issue with regards to obesity in the United States. In addition to this, increased plasma triglyceride levels (hypertriglyceridemia) is very unhealthy and is the leading cause of Coronary Artery Disease in America. LPL is an enzyme that helps combat this disease by breaking down the excess triglycerides that block the arteries of your heart. Very similarly, Chylomicronemia, a high level of triglycerides in the blood, causes buildup of chylomicrons (ultra-low-density lipoproteins) and leads to similar diseases. Without LPL in the body, developing coronary & metabolic (liver & pancreas) based diseases are at a higher likelihood | |
| + | |||
== Structural highlights == | == Structural highlights == | ||
This will be the structural highlights | This will be the structural highlights | ||
Revision as of 19:09, 5 April 2021
=Lipoprotein Lipase Structure=
| |||||||||||
References
Student Contributors
- Giselle Flores
- Dustin Soe
- Maggie Stopa
